NCT00588913View on ClinicalTrials.gov

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2009

Conditions
Kidney CancerMetastatic Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

zoledronic acid

Trial Locations (2)

606-8507

Kyoto University Hospital, Kyoto

162-8666

Tokyo Women's Medical University, Tokyo

All Listed Sponsors
lead

Tokyo Women's Medical University

OTHER

NCT00588913 - Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases | Biotech Hunter | Biotech Hunter